LexDanaLexDanabeta
Inventor

Philip E. Hass

Inventor
Moss Beach, CA, US

Overview

20→
Patents
2003–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 20 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C12NMicroorganisms or enzymes9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
C12YEnzymes1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,130,791Methods for treating metabolic syndrome using IL-22 Fc fusion proteins202110,961,313Anti-factor D antibody variant conjugates and uses thereof202110,723,795Anti-interleukin-33 antibodies and uses thereof202010,654,932Anti-factor D antibody variant conjugates and uses thereof202010,584,155Pharmaceutical compositions of IL-22 Fc fusion proteins202010,544,198Methods of accelerating or improving wound healing using IL-22 FC fusion proteins202010,179,821Anti-factor D antibodies201910,160,793Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins201810,093,730Anti-interleukin-33 antibodies and uses thereof201810,087,227Nucleic acids encoding IL-22 Fc fusion proteins201810,011,654Antibodies directed to IL-17A/IL-17F heterodimers20189,815,880'IL-22 Fc fusion proteins'20178,497,094'Prevention and treatment of complement-associated eye conditions'20138,268,310'Prevention and treatment of complement-associated eye conditions'20128,007,791'Prevention and treatment of complement-associated eye conditions'20117,930,109'Crystal structure of CRIg and C3b:CRIg complex'20117,776,573'Crystal structure of CRIg and C3b:CRIg complex'20107,354,585'Methods of treating coagulapathic or thrombotic disorders'20087,049,411'Human anti-factor IX/IXa antibodies'20066,624,295'Human anti-factor IX/IXa antibodies'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2021Patents assigned to GENENTECH INC (20)· patent assignee history
2003–2021Based in Moss Beach, CA, US· patent location history
2012–2013Patents assigned to HASS PHILIP (2)· patent assignee history
2012–2013Patents assigned to JIANPING YIN (2)· patent assignee history
2012–2013Patents assigned to KATSCHKE JR KENNETH (2)· patent assignee history
2012–2013Patents assigned to STEFFEK MICAH (2)· patent assignee history
2020–2021Based in South San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENENTECH INC202003–2021
HASS PHILIPself22012–2013
JIANPING YIN22012–2013
KATSCHKE JR KENNETH22012–2013
STEFFEK MICAH22012–2013
Locations
LocationPatentsSpan
Moss Beach, California, US182003–2021
South San Francisco, California, US22020–2021